Skip to main content
Caplight Logo









IBEX Medical Systems

IBEX Medical Systems

Private
South KoreaHealthcare & Life Scienceshttps://ibex.co.kr/kr/

Last Round

Series C

May 16, 2025

Est. Valuation

$57.61M

Total Funding Raised

$15.99M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

IBEX Medical Systems is a medical device company that manufactures and distributes hyperbaric oxygen therapy (HBOT) chambers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

hyperbaric oxygen therapyHBOThyperbaric chambermedical device manufactureroxygen therapy deviceMonoplace chamberMultiplace chamberbarotrauma preventionAnti-Barotrauma technologyremote patient monitoringAI-augmented medical devicetranscutaneous oxygen monitoringtcpO2 monitoringhyperhidrosis treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IBEX Medical Systems Comparables

Compare IBEX Medical Systems with similar companies based on industry and business-model similarity.

IBEX Medical Systems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Environmental Tectonics Corporation
78%

IBEX Medical Systems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMay 16, 2025
Series ANov 10, 2020

Key People

Founding team and executive leadership

Brian SOKO YOON

CEO

Executive Team

IBEX Medical Systems Investors

Notable investors and investment history

IBEX Medical Systems investors
InvestorRounds
Smilegate InvestmentSeries B
Bithumb KoreaSeries C
ROI Investment PartnersSeries C
KB Financial GroupSeries C
Lifecore PartnersSeries A
Capstone Partners KoreaSeries B
Tigris InvestmentSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2026

    Grew 50% QoQ from 6 to 9 employees.

  • May 19, 2026

    Monthly visitors increased 66% MoM, reaching 18K.

IBEX Medical Systems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

IBEX Medical Systems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about IBEX Medical Systems's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range10
Year Founded2000
Last FundingMay 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?